News
Rachel Hemsley appointed to the BioPartner Advisory Board
-Dr Rachel Hemsley, Global Head of Business Development at XenoGesis, has been appointed to the Advisory Board of BioPartner, the…
XenoGesis reports rapid export growth
-XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from…
XenoGesis chosen as CRO partner for Medicines Discovery Catapult Virtual R&D group
-The UK government’s Medicines Discovery Catapult has selected XenoGesis as a CRO partner to support its Virtual R&D Discovery Services…
XenoGesis to exhibit at the annual Anglonordic Life Science Conference
-XenoGesis has confirmed that it will be exhibiting at the 16th Annual Anglonordic Life Science Conference in London this May.…
Making Pharmaceuticals
-Richard Weaver will be presenting at the Making Pharmaceuticals exhibition and conference next week at the Ricoh Arena in Coventry.…